IDXX – IDEXX Laboratories, Inc.
Float Short %
2.59
Margin Of Safety %
-14
Put/Call OI Ratio
1.46
EPS Next Q Diff
-0.73
EPS Last/This Y
1.83
EPS This/Next Y
1.45
Price
641.13
Target Price
722.73
Analyst Recom
2
Performance Q
21.68
Relative Volume
0.56
Beta
1.59
Ticker: IDXX
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-08-15 | IDXX | 650.79 | 1.47 | 1.26 | 9069 |
| 2025-08-18 | IDXX | 637.74 | 1.30 | 20.70 | 5962 |
| 2025-08-19 | IDXX | 636.6 | 1.51 | 2.44 | 6532 |
| 2025-08-20 | IDXX | 639.8 | 1.53 | 1.65 | 6604 |
| 2025-08-21 | IDXX | 632.92 | 1.53 | 2.00 | 6660 |
| 2025-08-22 | IDXX | 645.24 | 1.53 | 1.14 | 6675 |
| 2025-08-25 | IDXX | 641.44 | 1.54 | 0.50 | 6746 |
| 2025-08-26 | IDXX | 641.91 | 1.55 | 0.54 | 6755 |
| 2025-08-27 | IDXX | 640.49 | 1.54 | 1.41 | 6772 |
| 2025-08-28 | IDXX | 647.24 | 1.54 | 1.27 | 6849 |
| 2025-08-29 | IDXX | 647.09 | 1.54 | 5.63 | 6870 |
| 2025-09-02 | IDXX | 639.52 | 1.55 | 2.41 | 6910 |
| 2025-09-03 | IDXX | 634.41 | 1.56 | 0.23 | 6962 |
| 2025-09-04 | IDXX | 640.22 | 1.42 | 8.00 | 7273 |
| 2025-09-05 | IDXX | 642.8 | 1.44 | 0.56 | 7329 |
| 2025-09-08 | IDXX | 653.34 | 1.44 | 0.78 | 7314 |
| 2025-09-09 | IDXX | 655.48 | 1.45 | 6.29 | 7359 |
| 2025-09-10 | IDXX | 637.68 | 1.47 | 2.32 | 7426 |
| 2025-09-11 | IDXX | 645.28 | 1.46 | 1.48 | 7356 |
| 2025-09-12 | IDXX | 641.49 | 1.46 | 2.75 | 7358 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-08-15 | IDXX | 651.06 | 11.8 | 25.5 | 12.57 |
| 2025-08-18 | IDXX | 637.58 | 11.8 | 5.3 | 12.57 |
| 2025-08-19 | IDXX | 636.71 | 11.8 | 28.8 | 12.60 |
| 2025-08-20 | IDXX | 639.84 | 11.8 | 37.3 | 12.60 |
| 2025-08-21 | IDXX | 632.97 | 11.8 | 17.5 | 12.60 |
| 2025-08-22 | IDXX | 645.47 | 11.8 | 55.9 | 12.60 |
| 2025-08-25 | IDXX | 641.19 | 11.8 | 22.5 | 12.60 |
| 2025-08-26 | IDXX | 641.72 | 11.8 | 31.8 | 12.60 |
| 2025-08-27 | IDXX | 640.69 | 11.8 | 29.0 | 12.60 |
| 2025-08-28 | IDXX | 647.03 | 11.8 | 43.3 | 12.60 |
| 2025-08-29 | IDXX | 647.03 | 11.8 | 29.6 | 12.60 |
| 2025-09-02 | IDXX | 639.43 | 11.8 | 16.1 | 12.60 |
| 2025-09-03 | IDXX | 634.00 | 11.8 | 167.0 | 12.60 |
| 2025-09-04 | IDXX | 640.29 | 11.8 | 193.2 | 12.60 |
| 2025-09-05 | IDXX | 642.99 | 11.8 | 184.7 | 12.60 |
| 2025-09-08 | IDXX | 652.83 | 11.8 | 200.7 | 12.60 |
| 2025-09-09 | IDXX | 655.01 | 11.8 | 183.8 | 12.60 |
| 2025-09-10 | IDXX | 637.67 | 11.8 | 140.5 | 12.60 |
| 2025-09-11 | IDXX | 645.16 | 11.8 | 195.0 | 12.60 |
| 2025-09-12 | IDXX | 641.13 | 11.8 | 170.2 | 12.60 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-08-15 | IDXX | -6.77 | 4.09 | 3.13 |
| 2025-08-18 | IDXX | -6.20 | 4.13 | 3.14 |
| 2025-08-19 | IDXX | -6.20 | 4.13 | 3.14 |
| 2025-08-20 | IDXX | -6.20 | 4.13 | 3.14 |
| 2025-08-21 | IDXX | -6.20 | 4.13 | 3.14 |
| 2025-08-22 | IDXX | -6.25 | 4.13 | 3.14 |
| 2025-08-25 | IDXX | -6.25 | -0.16 | 3.14 |
| 2025-08-26 | IDXX | -6.47 | -0.16 | 3.14 |
| 2025-08-27 | IDXX | -6.47 | -0.16 | 2.31 |
| 2025-08-28 | IDXX | -6.47 | -0.16 | 2.31 |
| 2025-08-29 | IDXX | -6.47 | -0.16 | 2.31 |
| 2025-09-02 | IDXX | -6.47 | -0.23 | 2.31 |
| 2025-09-03 | IDXX | -6.47 | -0.23 | 2.31 |
| 2025-09-04 | IDXX | -6.47 | -0.23 | 2.31 |
| 2025-09-05 | IDXX | -6.47 | -0.23 | 2.31 |
| 2025-09-08 | IDXX | -6.47 | -0.29 | 2.31 |
| 2025-09-09 | IDXX | -6.47 | -0.29 | 2.31 |
| 2025-09-10 | IDXX | -6.53 | -0.29 | 2.31 |
| 2025-09-11 | IDXX | -6.53 | -0.29 | 2.59 |
| 2025-09-12 | IDXX | -6.53 | -0.29 | 2.59 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
3.63
Avg. EPS Est. Current Quarter
3.13
Avg. EPS Est. Next Quarter
2.9
Insider Transactions
-6.53
Institutional Transactions
-0.29
Beta
1.59
Average Sales Estimate Current Quarter
1069
Average Sales Estimate Next Quarter
1053
Fair Value
553.92
Quality Score
97
Growth Score
94
Sentiment Score
73
Actual DrawDown %
9.3
Max Drawdown 5-Year %
-54
Target Price
722.73
P/E
53.37
Forward P/E
45.3
PEG
3.65
P/S
12.7
P/B
35.23
P/Free Cash Flow
65.4
EPS
12.01
Average EPS Est. Cur. Y
12.6
EPS Next Y. (Est.)
14.06
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
24.41
Relative Volume
0.56
Return on Equity vs Sector %
42.7
Return on Equity vs Industry %
56.7
EPS 1 7Days Diff
0.1
EPS 1 30Days Diff
0.41
EBIT Estimation
170.2
IDEXX Laboratories, Inc.Sector: Healthcare
Industry: Diagnostics & Research
Employees: 11000
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, it offers diagnostic tests, services, and related instrumentation for manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
stock quote shares IDXX – IDEXX Laboratories, Inc. Stock Price stock today
news today IDXX – IDEXX Laboratories, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch IDXX – IDEXX Laboratories, Inc. yahoo finance google finance
stock history IDXX – IDEXX Laboratories, Inc. invest stock market
stock prices IDXX premarket after hours
ticker IDXX fair value insiders trading